EDGAR Filing Documents for 0001193125-11-050393

Form 8-K - Current report:

SEC Accession No. 0001193125-11-050393

Filing Date

2011-03-01

Accepted

2011-02-28 18:56:40

Documents

Period of Report

2011-02-23

Items

Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	16273
2	PRESS RELEASE DATED FEBRUARY 28, 2011, REPORTING OPERATING RESULTS	dex991.htm	EX-99.1	154543
3	PRESS RELEASE DATED FEBRUARY 23, 2011, ANNOUNCING PRESENTATION AT THREE HEALTH	dex992.htm	EX-99.2	10796
4	PRESS RELEASE DATED FEBRUARY 23, 2011, ANNOUNCING A CONFERENCE CALL TO PROVIDE	dex993.htm	EX-99.3	14663
5	PRESS RELEASE DATED FEBRUARY 24, 2011, ANNOUNCING ANTICIPATION OF RECEIVING	dex994.htm	EX-99.4	15889
	Complete submission text file	0001193125-11-050393.txt		213782

Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560

Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000

SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 11648338
SIC: 2834 Pharmaceutical Preparations